Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9609 |
GRK5-IN-2
|
GRK | GPCR/G Protein |
GRK5-IN-2 是基于吡啶的双环化合物,抑制 G 蛋白偶联受体激酶 5 。它调节胰岛素的表达和/或释放,在代谢疾病中有研究价值。 | |||
T62599 |
GRK5-IN-3
|
||
GRK5-IN-3 是一种 G 蛋白偶联受体激酶 5 (GRK5) 的共价抑制剂。GRK5-IN-3 对 GRK5 (IC50: 0.22 μM) 和 GRK6 (IC50: 0.41 μM)有显著的抑制作用。 | |||
T63203 | GRK5-IN-4 | ||
GRK5-IN-4 是选择性的、有效的、共价 GRK5(G 蛋白偶联受体激酶 5) 抑制剂(IC50: 1.1 μM)。GRK5-IN-4 对 GRK5 的选择性是 GRK2 的90倍。GRK5-IN-4 能够用于研究心力衰竭。 | |||
T14989 |
CMPD101
|
ROCK; GRK; PKC | Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; GPCR/G Protein; Stem Cells |
CMPD101 是膜透性的 GRK2/3高选择性小分子抑制剂,IC50分别为 18 nM 和 5.4 nM。它针对 GRK1、GRK5 ROCK-2 和 PKCα 的选择性较小,IC50值分别为 3.1 μM,2.3 μM,1.4 μM 和 8.1 μM,可研究心衰疾病。 | |||
T3498 |
CCG215022
|
GRK; PKA | GPCR/G Protein; Tyrosine Kinase/Adaptors |
CCG215022 是 G 蛋白偶联受体激酶抑制剂,能够作用于 GRK2 (IC50:0.15±0.07 μM),GRK5 (IC50:0.38±0.06 μM) 和 GRK1 (IC50:3.9±1 μM)。 | |||
T13714L |
GRK2-IN-1 hydrochloride (2055990-90-2 free base)
GRK2-IN-1 hydrochloride |
GRK | GPCR/G Protein |
GRKs-IN-1 hydrochloride has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50: 130 nM) and GRK5 (IC50: 7.1 μM). | |||
T13714 |
CCG258208
GRK2-IN-1 |
GRK | GPCR/G Protein |
GRKs-IN-1 has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50: 130 nM) and GRK5 (IC50: 7.1 μM). | |||
T63340 |
CCG-273220
|
||
CCG-273220 是 G 蛋白偶联受体 (GPCR) 激酶 5 (GRK5) 共价抑制剂 (IC50: 220 nM)。CCG-273220 可以共价结合GRK5亚家族特异性残基 Cys474 ,而对GRK5的选择性比 GRK2 高。 | |||
T62986 |
CCG-271423
|
||
CCG-271423 是一种有效的、选择性的 GRK5 抑制剂,作用于 GRK5 (IC50: 0.0021 μM) 和 GRK2 (IC50: 44 μM)。CCG-271423 能够降低 Ca2+瞬态,抑制心肌细胞收缩能力。 | |||
T63640 | CCG-273463 | ||
CCG-273463 是有效的、共价的、选择性的 GRK5 抑制剂 (IC50: 9 nM)。CCG-273463 能够用于研究心力衰竭、肥厚型心肌病和癌症。 | |||
T82258 | GRL018-21 | ||
GRL018-21为一种高效、高选择性G蛋白偶联受体激酶5 (GRK5) 抑制剂,其IC50值仅为10 nM。 | |||
T35875 | CCG258208 hydrochloride | ||
GRKs-IN-1 hydrochloride, Compound 14as, has remarkable potency against and selectivity for G protein-coupled receptor kinase 2 GRK2 (IC50=130 nM) and GRK5 (IC50=7.1 μM).GRKs-IN-1 hydrochloride is a derivative 14as of paroxetine, shows a 100-fold improvement in cardiomyocyte contractility assays over paroxetine[1]. [1]. Waldschmidt HV, et al. Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2Inhibitors Based on Paroxetine. J Med Chem. 2017 Apr 13;60(7):305... | |||
T64266 | KR-39038 | ||
KR-39038 是一种口服具有活力的 GRK5 (G 蛋白偶联受体激酶 5) 抑制剂 (IC50: 0.02 μM)。KR-39038 能够抑制新生儿心肌细胞的 HDAC5 通路,明显抑制血管紧张素 II 诱导的细胞肥大,具有显著的抗心肌肥厚和改善心功能作用。KR-39038 能够用于进行心力衰竭的研究。 |